Has Fardina Malik, MD received payments from drug or device companies?

Yes. Drug and device makers reported $17,465 in general payments to Fardina Malik, MD across 21 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Fardina Malik, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Fardina Malik, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Fardina Malik, MD

Rheumatology · Madison, WINPI 1053556928

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,668 of the $17,465 with a category attached, or 61.1%. 5 manufacturers reported payments, led by Pfizer at 43.8% of the total. Reporting peaked in 2023 at $8,827 and has fallen 92.8% since, to $638 in 2024. Among rheumatology clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,465in general payments, 2019–2025

Across 21 payments — averaging $831.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$8K
UCB, Inc.$6K
UCB SA$3K
Novartis$313
Amgen$167

$428,759in research payments, 2019–2025

Across 10 payments — averaging $42,876 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novartis$407K
AbbVie$22K

What the payments were for

Consulting fees$10,66861%
Speaking & faculty fees$4,95528%
Travel & lodging$1,0736%
Food & beverage$6033%
Education$1671%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	8	$7,643
UCB, Inc.	3	$6,368
UCB SA	1	$2,975
Novartis	7	$313
Amgen	2	$167

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XELJANZ$7,615
Bimzelx$3,180
Cimzia$2,550
COSENTYX$125

How this compares

$17,465 in reported general payments places this provider in the 90th percentile of 120 rheumatology providers in Wisconsin.

See all rheumatology providers in Wisconsin →

Medicare billing

Part B allowed, 2024

$27,704

Medicare patients

120

Services billed

319

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BenlystaBelimumab	11	$50,624
RasuvoMethotrexate/Pf	18	$14,364
Leflunomide	39	$4,907
MethotrexateMethotrexate Sodium	77	$2,181
Hydroxychloroquine Sulfate	40	$1,778
Colchicine	18	$989
Prednisone	62	$953
Sulfasalazine	32	$917
Methylprednisolone	15	$182
Folic Acid	16	$159
Alendronate Sodium	11	$57

Paid to pharmacies, not to this prescriber.

Other rheumatology in Madison

Sara McCoyMadison$80K
Michael WalshMadison$16K
Tiffany LinMadison$5K
Carmen CampbellMadison$5K
Jilaine Bolek BerquistMadison$2K
John JuozeviciusMadison$1K
Kurt OelkeGlendale$750K
Daniel MaloneBeaver Dam$505K
John AlbertGlendale$369K
Taraneh MehraniMenomonee Falls$176K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →